HDOC
Investment Objective
HDOC seeks to replicate, to the extent possible and net of expenses, the performance of an index that is designed to provide exposure to the performance of global, publicly listed companies generally engaged in the field of telemedicine and digital health, as well as applications thereof. Currently, HDOC seeks to replicate, directly or indirectly, the performance of the Solactive Telemedicine & Digital Health Index, net of expenses, by investing primarily in the Global X Telemedicine & Digital Health ETF. HDOC seeks to hedge any U.S. dollar portfolio exposure back to the Canadian dollar at all times.
Fund Details
The NAV chart above only shows the historical daily net asset value per unit (NAV) of the ETF, and identifies the various distributions made by the ETF, if any. The distributions are not treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses. The chart is not a performance chart and is not indicative of future NAV values which will vary.
The Growth of 10K chart above is based on the historical daily net asset value per unit (NAV) of the ETF, and represents the value of an initial investment into the ETF of $10,000 since its inception, on a total return basis. Distributions, if any, are treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses where paid by the fund. The chart is not a performance chart and is not indicative of future value which will vary.
Annualized Performance (%) *
Investment fund regulations restrict the presentation of performance figures until a fund reaches its one-year anniversary.
Calendar Year Performance (%) *
Investment fund regulations restrict the presentation of performance figures until a fund reaches its one-year anniversary.
Distributions
Year | Ex-Dividend Date | Record Date | Payment Date | Payment Amount | Reinvested Non-Cash Distributions | Distribution Period |
---|---|---|---|---|---|---|
2021 | 12/30/2021 | 12/31/2021 | 01/13/2022 | 0.64456 | Annually |
Top 10 Holdings
As at August 31, 2023Security Name | Weight |
---|---|
R1 RCM Inc | 5.03% |
Pacific Biosciences of California Inc | 5.02% |
AMN Healthcare Services Inc | 4.56% |
Privia Health Group Inc | 4.44% |
Omnicell Inc | 4.27% |
Laboratory Corp of America Hldgs | 4.17% |
Agilent Technologies Inc | 4.04% |
Veracyte Inc | 3.93% |
Teladoc Health Inc | 3.90% |
Alibaba Health Information Tech Ltd | 3.65% |
Education
Regulatory and Legal
Investment Objective
HDOC seeks to replicate, to the extent possible and net of expenses, the performance of an index that is designed to provide exposure to the performance of global, publicly listed companies generally engaged in the field of telemedicine and digital health, as well as applications thereof. Currently, HDOC seeks to replicate, directly or indirectly, the performance of the Solactive Telemedicine & Digital Health Index, net of expenses, by investing primarily in the Global X Telemedicine & Digital Health ETF. HDOC seeks to hedge any U.S. dollar portfolio exposure back to the Canadian dollar at all times.
Fund Details
As at August 01, 2023
As at August 01, 2023
The NAV chart above only shows the historical daily net asset value per unit (NAV) of the ETF, and identifies the various distributions made by the ETF, if any. The distributions are not treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses. The chart is not a performance chart and is not indicative of future NAV values which will vary.
The Growth of 10K chart above is based on the historical daily net asset value per unit (NAV) of the ETF, and represents the value of an initial investment into the ETF of $10,000 since its inception, on a total return basis. Distributions, if any, are treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses where paid by the fund. The chart is not a performance chart and is not indicative of future value which will vary.
Annualized Performance (%)
Investment fund regulations restrict the presentation of performance figures until a fund reaches its one-year anniversary.
Calendar Year Performance (%)
Investment fund regulations restrict the presentation of performance figures until a fund reaches its one-year anniversary.
Distributions
Year | Ex-Dividend Date | Record Date | Payment Date | Payment Amount | Reinvested Non-Cash Distributions | Distribution Period |
---|---|---|---|---|---|---|
2021 | 12/30/2021 | 12/31/2021 | 01/13/2022 | 0.64456 | Annually |
Top 10 Holdings
As at August 31, 2023Security Name | Weight |
---|---|
R1 RCM Inc | 5.03% |
Pacific Biosciences of California Inc | 5.02% |
AMN Healthcare Services Inc | 4.56% |
Privia Health Group Inc | 4.44% |
Omnicell Inc | 4.27% |
Laboratory Corp of America Hldgs | 4.17% |
Agilent Technologies Inc | 4.04% |
Veracyte Inc | 3.93% |
Teladoc Health Inc | 3.90% |
Alibaba Health Information Tech Ltd | 3.65% |